Copy Link Print Information

Chroman 1

70 Cited Publications
Revisión del cliente

Based on 70 publication(s) in Google Scholar

Chroman 1 is a highly potent and selective ROCK inhibitor. Chroman 1 is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 also has inhibitory activity against MRCK, with an IC50 of 150 nM.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 98.97%
  • No. CAS: 1273579-40-0
  • Fòrmula: C24H28N4O4
  • Peso molecular:436.50
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Chroman 1 Chemical Structure
    Chroman 1 Chemical Structure
  • Experimental Validation Results for Chroman 1
  • Experimental Validation Results for Chroman 1
  • Experimental Validation Results for Chroman 1
  • Experimental Validation Results for Chroman 1
  • Experimental Validation Results for Chroman 1
No. CAS: 1273579-40-0
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Chroman 1:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Chroman 1

More
Customer Validation & Images
Cell Imaging/StainingCell Proliferation/Viability AssayWB
  • Cell Imaging/Staining
  • Cell Imaging/Staining
  • Cell Imaging/Staining
  • Cell Proliferation/Viability Assay
  • WB

Ver todos los productos específicos de isoformas ROCK

More
Keywords
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Chroman 1 Chemical Structure
    Chroman 1 Chemical Structure
    1/16
  • 1/16

    Chroman 1 purchased from MedChemExpress. Usage Cited in: J Med Virol. 2024 Apr;96(4):e29579. [Abstract]

    Customer Validation
     Chroman 1 (50 nM; 24 h). Survivals of differentiated hiPSCs - anterior foregut endoderm (left) and AOs (right) were improved with CEPT cocktail (Chroman 1, Emricasan, Polyamines and trans-ISRIB) treatment compared to Y27632. Phase contrast images were taken after 24 h of seeding (hiPSC) and 8 days of seeding (AOs).

  • 1/16

    Chroman 1 purchased from MedChemExpress. Usage Cited in: Nat Protoc. 2023 Jan;18(1):58-80. [Abstract]

    Customer Validation
     Chroman 1 (50 nM; 5 min). Fast-acting CEPT (Chroman 1, Emricasan, Polyamines, trans-ISRIB) is cytoprotective and maintains cell morphology of WA09 dissociated cells, whereas ongoing cell contractions lead to abnormal cells in the presence of Y-27632.

  • 1/16

    Chroman 1 purchased from MedChemExpress. Usage Cited in: Nat Methods. 2021 May;18(5):528-541. [Abstract]

    Customer Validation
     Improved survival of hESCs (WA09) with Chroman 1 (50 nM; 24 h) treatment.

  • 1/16

    Chroman 1 purchased from MedChemExpress. Usage Cited in: Nat Methods. 2021 May;18(5):528-541. [Abstract]

    Customer Validation
     Chroman 1 (50 nM; 24 h). hESCs (WA09) cells were dissociated with Accutase and plated on VN in E8 medium. CTG was used to quantify viable cells 24 h post-seeding.

  • 1/16

    Chroman 1 purchased from MedChemExpress. Usage Cited in: Nat Methods. 2021 May;18(5):528-541. [Abstract]

    Customer Validation
     Chroman 1 (50 nM; 24 h). Total caspase-3 expression in hESCs (WA09) in comparison to their lineage-committed precursors after directed differentiation into ectoderm (PAX6), mesoderm (Brachyury), and endoderm (SOX17). Note that caspase-3 is strongly expressed in the pluripotent state and downregulated upon differentiation.

  • Chroman 1